The lung microbiome after lung transplantation

References

• Yusen RD, Christie JD, Edwards LB, et al. The registry of the international society for heart and lung transplantation: thirtieth adult lung and heart-lung transplant report-2013; focus theme: age. J Heart Lung Transplant 2013;32(10):965-78
   PubMed Web of Science ®Google Scholar
• Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 2012;31(10):1073-86
   PubMed Web of Science ®Google Scholar
• Christie JD, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: twenty-eighth adult lung and heart-lung transplant report – 2011. J Heart Lung Transplant 2011;30(10):1104-22
   PubMed Web of Science ®Google Scholar
• Orens JB, Garrity ER. Jr. General overview of lung transplantation and review of organ allocation. Proc Am Thorac Soc 2009;6(1):13-19
   PubMedGoogle Scholar
• Botha P, Archer L, Anderson RL, et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008;85(5):771-4
   PubMed Web of Science ®Google Scholar
• Chambers DC, Davies B, Mathews A, et al. Bronchiolitis obliterans syndrome, hypogammaglobulinemia, and infectious complications of lung transplantation. J Heart Lung Transplant 2013;32(1):36-43
   Google Scholar
• Gottlieb J, Schulz TF, Welte T, et al. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation 2009;87(10):1530-7
   Google Scholar
• Gregson AL, Wang X, Weigt SS, et al. Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation. Am J Respir Crit Care Med 2013;187(5):518-26
   PubMed Web of Science ®Google Scholar
• Hayes D Jr, Mansour HM, Kirkby S, Phillips AB. Rapid acute onset of bronchiolitis obliterans syndrome in a lung transplant recipient after respiratory syncytial virus infection. Transpl Infect Dis 2012;14(5):548-50
   Google Scholar
• Khalifah AP, Hachem RR, Chakinala MM, et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004;170(2):181-7
   Web of Science ®Google Scholar
• Kroshus TJ, Kshettry VR, Savik K, et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997;114(2):195-202
   Google Scholar
• Shalhoub S, Husain S. Community-acquired respiratory viral infections in lung transplant recipients. Curr Opin Infect Dis 2013;26(4):302-8
   Google Scholar
• Snyder LD, Finlen-Copeland CA, Turbyfill WJ, et al. Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am J Respir Crit Care Med 2010;181(12):1391-6
   PubMed Web of Science ®Google Scholar
• Aagaard K, Petrosino J, Keitel W, et al. The human microbiome project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J 2013;27(3):1012-22
   PubMed Web of Science ®Google Scholar
• Morgan XC, Huttenhower C. Chapter 12: human microbiome analysis. PLoS Comput Biol 2012;8(12):e1002808
   PubMed Web of Science ®Google Scholar
• DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006;72(7):5069-72
   PubMed Web of Science ®Google Scholar
• Dickson RP, Erb-Downward JR, Huffnagle GB. The role of the bacterial microbiome in lung disease. Exp Rev Res Med 2013;7(3):245-57
   PubMed Web of Science ®Google Scholar
• Goddard AF, Staudinger BJ, Dowd SE, et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci USA 2012;109(34):13769-74
   PubMed Web of Science ®Google Scholar
• Cabrera-Rubio R, Garcia-Nunez M, Seto L, et al. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J Clin Microbiol 2012;50(11):3562-8
   PubMed Web of Science ®Google Scholar
• Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 2011;184(8):957-63
   PubMed Web of Science ®Google Scholar
• Morris A, Beck JM, Schloss PD, et al. Comparison of the respiratory microbiome in healthy non-smokers and smokers. Am J Respir Crit Care Med 2013;187(10):1067-75
   PubMed Web of Science ®Google Scholar
• Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS ONE 2011;6(2):e16384
   PubMed Web of Science ®Google Scholar
• Rogers G, Van Der Gast C, Hopkins P, et al. The lower airway bacterial microbiota in patients with and without bronchiolitis obliterans syndrome following lung transplantation. In: C14. clinical and translational advances in lung transplantation. American Thoracic Society; 2013. p. A3780
   Google Scholar
• Pezzulo AA, Nassar B, Gansemer ND, et al. A diverse landscape of DNA from live and dead bacteria in the airways. In: C56. bench to bedside advances in bronchiectasis. American Thoracic Society; p. A6406
   Google Scholar
• Borewicz K, Pragman AA, Kim HB, et al. Longitudinal analysis of the lung microbiome in lung transplantation. FEMS Microbiol Lett 2013;339(1):57-65
   PubMed Web of Science ®Google Scholar
• Sze MA, Dimitriu PA, Hayashi S, et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185(10):1073-80
   PubMed Web of Science ®Google Scholar
• Han MK, Erb-Downward J, Zhou Y, et al. The IPF microbiome: analysis from the COMET study. In: C13. influence of the microbiome on airway mucosal responses in health and disease. American Thoracic Society; 2013. p. A3769
   Google Scholar
• Molyneaux PL, Russell AM, Cox MJ, et al. The respiratory microbiome in idiopathic pulmonary fibrosis. In: C103. pathogenesis, biomarkers, and risk factors for interstitial lung disease: from bench to bedside. American Thoracic Society; 2012. p. A5174
   Google Scholar
• Fodor AA, Klem ER, Gilpin DF, et al. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One 2012;7(9):e45001
   PubMed Web of Science ®Google Scholar
• Tunney MM, Einarsson GG, Wei L, et al. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med 2013;187(10):1118-26
   PubMed Web of Science ®Google Scholar
• Vital D, Hofer M, Benden C, et al. Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients. Respiration 2013;86(1):25-31
   Google Scholar
• Alexander BD, Petzold EW, Reller LB, et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 2008;8(5):1025-30
   PubMed Web of Science ®Google Scholar
• Aris RM, Routh JC, LiPuma JJ, et al. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001;164(11):2102-6
   PubMed Web of Science ®Google Scholar
• Chaparro C, Maurer J, Gutierrez C, et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001;163(1):43-8
   PubMed Web of Science ®Google Scholar
• De Soyza A, Meachery G, Hester KL, et al. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. J Heart Lung Transplant 2010;29(12):1395-404
   PubMed Web of Science ®Google Scholar
• Liou TG, Adler FR, Fitzsimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001;153(4):345-52
   PubMed Web of Science ®Google Scholar
• Dickson RP, Erb-Downward J, Britt ZE, et al. The lung microbiota is distinct following lung transplantation and is associated with bronchiolitis obliterans syndrome. In: A104. lung transplantation: clinical and translational advances. American Thoracic Society; 2013. p. A2209
   Google Scholar
• Willner DL, Hugenholtz P, Yerkovich ST, et al. Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2013;187(6):640-7
   Web of Science ®Google Scholar
• Fisichella PM, Davis CS, Kovacs EJ. A review of the role of GERD-induced aspiration after lung transplantation. Surg Endosc 2012;26(5):1201-4
   Google Scholar
• Garrity ER Jr. Gastroesophageal reflux disease and bronchiolitis obliterans syndrome: where are we today? J Heart Lung Transplant 2013;32(6):579-80
   Google Scholar
• Hartwig MG, Davis RD. Gastroesophageal reflux disease-induced aspiration injury following lung transplantation. Curr Opin Organ Transplant 2012;17(5):474-8
   Google Scholar
• Hoppo T, Komatsu Y, Jobe BA. Gastroesophageal reflux disease and patterns of reflux in patients with idiopathic pulmonary fibrosis using hypopharyngeal multichannel intraluminal impedance. Dis Esophagus 2012. [Epub ahead of print]
   Google Scholar
• Murthy SC, Nowicki ER, Mason DP, et al. Pretransplant gastroesophageal reflux compromises early outcomes after lung transplantation. J Thorac Cardiovasc Surg 2011;142(1):47-52. e43
   Google Scholar
• Charlson ES, Diamond JM, Bittinger K, et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med 2012;186(6):536-45
   PubMed Web of Science ®Google Scholar
• Luna RA, Sagar M, Crabtree SA, et al. Characterization of the lung microbiome in pediatric lung transplant recipients. J Heart Lung Transplant 2013;32(4 Supplement):S291
   Google Scholar
• Dickson RP, Britt ZE, Erb-Downward J, et al. Lung microbiota diversity is decreased among lung transplant recipients. In: C14. clinical and translational advances in lung transplantation. American Thoracic Society; 2013. p. A3781
   Google Scholar
• Willner D, Ab-Ghani NA, Yerkovich S, et al. Longitudinal holistic profiling of the lung transplant microbiome. J Heart Lung Transplant 2013;32(4 Suppl):S10-11
   Google Scholar
• Todd JL, Palmer SM. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest 2011;140(2):502-8
   PubMed Web of Science ®Google Scholar
• Willner D, Hugenholtz P, Tan ME, et al. 68 distinct microbial signatures of healthy and failing lung allografts. J Heart Lung Transplant 2012;31(4 Suppl):S32
   Google Scholar
• Poroyko V, Semenyuk E, Xu Z, et al. Longitudinal study of pulmonary microbial dynamics in lung transplant recipients with and without bronchiolitis obliterans syndrome. J Heart Lung Transplant 2013;32(4 Suppl):S34
   Google Scholar
• Hayes D Jr, Weiland A, Kirkby S, et al. Gram-negative infection and bronchiectasis in lung transplant recipients with bronchiolitis obliterans syndrome. Thorac Cardiovasc Surg 2013;61(3):240-5
   Google Scholar
• Vos R, Vanaudenaerde BM, Geudens N, et al. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? Eur Respir J 2008;31(5):1037-45
   Google Scholar
• Gottlieb J, Mattner F, Weissbrodt H, et al. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis. Respir Med 2009;103(5):743-9
   Web of Science ®Google Scholar
• Jain R, Hachem RR, Morrell MR, et al. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant 2010;29(5):531-7
   Web of Science ®Google Scholar
• Murphy DM, Forrest IA, Corris PA, et al. Azithromycin attenuates effects of lipopolysaccharide on lung allograft bronchial epithelial cells. J Heart Lung Transplant 2008;27(11):1210-16
   PubMed Web of Science ®Google Scholar
• Garantziotis S, Howell DN, McAdams HP, et al. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest 2001;119(4):1277-80
   Google Scholar
• Halloran K, Chang J, Kapasi A, et al. Predictors of chronic lung allograft dysfunction (CLAD) following respiratory viral infection (RVI). In: The International Society for heart and lung transplantation. 33rd Annual Meeting and Scientific Sessions; Montréal, QC, CA, USA;2013
   Google Scholar
• Kumar D, Husain S, Chen MH, et al. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation 2010;89(8):1028-33
   PubMed Web of Science ®Google Scholar
• Neurohr C, Huppmann P, Leuchte H, et al. Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome? Am J Transplant 2005;5(12):2982-91
   Web of Science ®Google Scholar
• Engelmann I, Welte T, Fuhner T, et al. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation. J Clin Virol 2009;45(1):47-53
   Google Scholar
• Westall GP, Michaelides A, Williams TJ, et al. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation. Transplantation 2003;75(12):2064-8
   Google Scholar
• Paraskeva M, Bailey M, Levvey BJ, et al. Cytomegalovirus replication within the lung allograft is associated with bronchiolitis obliterans syndrome. Am J Transplant 2011;11(10):2190-6
   PubMed Web of Science ®Google Scholar
• Fiser SM, Tribble CG, Long SM, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002;73(4):1041-7. discussion 1047-1048
   Google Scholar
• Tamm M, Aboyoun CL, Chhajed PN, et al. Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2004;170(10):1120-3
   Web of Science ®Google Scholar
• Manuel O, Kumar D, Moussa G, et al. Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis. Transplantation 2009;87(5):719-25
   Google Scholar
• Chmiel C, Speich R, Hofer M, et al. Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis 2008;46(6):831-9
   Google Scholar
• Ruttmann E, Geltner C, Bucher B, et al. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation. Transplantation 2006;81(10):1415-20
   PubMed Web of Science ®Google Scholar
• Weigt SS, Elashoff RM, Huang C, et al. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Am J Transplant 2009;9(8):1903-11
   PubMed Web of Science ®Google Scholar
• Ames NJ, Sulima P, Ngo T, et al. A characterization of the oral microbiome in allogeneic stem cell transplant patients. PloS One 2012;7(10):e47628
   Google Scholar
• Sheehy EC, Beighton D, Roberts GJ. The oral microbiota of children undergoing liver transplantation. Oral Microbiol Immunol 2000;15(3):203-10
   Google Scholar
• Diaz PI, Hong BY, Frias-Lopez J, et al. Transplantation-associated long-term immunosuppression promotes oral colonization by potentially opportunistic pathogens without impacting other members of the salivary bacteriome. Clin Vaccine Immunol 2013;20(6):920-30
   Google Scholar
• Murphy S, Nguyen VH. Role of gut microbiota in graft-versus-host disease. Leuk Lymphoma 2011;52(10):1844-56
   PubMed Web of Science ®Google Scholar
• Hartman AL, Lough DM, Barupal DK, et al. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci USA 2009;106(40):17187-92
   Web of Science ®Google Scholar
• Wu ZW, Ling ZX, Lu HF, et al. Changes of gut bacteria and immune parameters in liver transplant recipients. Hepatobiliary Pancreat Dis Int 2012;11(1):40-50
   PubMed Web of Science ®Google Scholar
• Xie YR, Liu SL, Liu X, et al. Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation. Transplant Proc 2011;43(10):3973-9
   PubMed Web of Science ®Google Scholar
• Oh PL, Martinez I, Sun Y, et al. Characterization of the ileal microbiota in rejecting and nonrejecting recipients of small bowel transplants. Am J Transplant 2012;12(3):753-62
   PubMed Web of Science ®Google Scholar
• Xie Y, Luo Z, Li Z, et al. Structural shifts of fecal microbial communities in rats with acute rejection after liver transplantation. Microb Ecol 2012;64(2):546-54
   Google Scholar
• Corbitt N, Kimura S, Isse K, et al. Gut bacteria drive Kupffer cell expansion via MAMP-mediated ICAM-1 induction on sinusoidal endothelium and influence preservation-reperfusion injury after orthotopic liver transplantation. Am J Pathol 2013;182(1):180-91
   Web of Science ®Google Scholar
• Wylie KM, Weinstock GM, Storch GA. Emerging view of the human virome. Transl Res 2012;160(4):283-90
   Google Scholar
• Willner D, Thurber RV, Rohwer F. Metagenomic signatures of 86 microbial and viral metagenomes. Environ Microbiol 2009;11(7):1752-66
   Google Scholar